Loading provider…
Loading provider…
Neurology Physician in Cincinnati, OH
NPI: 1215190590Primary Practice Location
DRAKE CENTER INC
151 W Galbraith Rd, Cincinnati, OH
Primary Employer
University of Cincinnati Physicians Company, LLC
ucphysicians.com
HQ Phone
Get MD Hani's Phone Numberphone_androidMobile
Get MD Hani's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
KY State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 58 | 83 |
| 2 | 95886Needle measurement and recording of electrical activity of muscles of arm or leg complete study | 22 | 31 |
| 3 | 99205New patient office or other outpatient visit, typically 60 minutes | 20 | 20 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 12 | 13 |
Authors: Tahseen Mozaffar, Mazen Dimachkie, Priya Kishnani, John Day, Kenneth Berger, Ozlem Goker-Alpan
Journal: JAMA Neurol
Emerging toxic neuropathies and myopathies.
Authors: @ValidYN, LastName, ForeName, Initials, AffiliationInfo
Journal: Neurol Clin
Publication Date: 2011-07-14
Lead Sponsor: University of Kansas Medical Center
Collaborators: Patient-Centered Outcomes Research Institute
Intervention / Treatment: DRUG: Duloxetine, DRUG: Pregabalin, DRUG: Nortriptyline, DRUG: Mexiletine
Lead Sponsor: Regeneron Pharmaceuticals
Intervention / Treatment: OTHER: Placebo, DRUG: Pozelimab, DRUG: Cemdisiran, DRUG: Pozelimab + Cemdisiran
Lead Sponsor: Genzyme, a Sanofi Company
Intervention / Treatment: DRUG: Alglucosidase alfa (GZ419829), DRUG: Avalglucosidase alfa (GZ402666)